Anish Sharda

Dr. Anish Sharda is an Assistant Professor of Medicine at Yale School of Medicine, specializing in classical hematology with clinical focus on bleeding, clotting, and platelet disorders. His NIH-funded research explores von Willebrand disease and vascular biology mechanisms.

Education:

• MBBS (Medical Degree), B.P. Koirala Institute of Health Sciences, Nepal (200X)
• Residency in Internal Medicine, University of Minnesota Medical Center (2011)
• Fellowship in Hematology/Oncology, Beth Israel Deaconess Medical Center & Harvard Medical School (2014)

Research Interests: Dr. Sharda’s work spans thrombosis, platelet biology, and vascular disorders. His lab investigates molecular regulators of von Willebrand factor maturation and novel treatments for bleeding disorders. Key projects include cryo-EM studies of platelet transporters (ABCC4) and antithrombotic drug mechanisms.

Key Publications: Recent studies include insights into platelet pharmacology via cryo-EM, aspirin prophylaxis in joint surgery, and protein isomerases in thrombus formation. His work bridges basic science and clinical applications in hematology.

Awards:

• JH Milstone Fund (2023)
• Forget Scholar (2022)
• Young Investigator Awards (2010-2013)

Advising & Grants: NIH grants support his lab’s research. Collaborates with institutions such as Beth Israel Deaconess Medical Center and Harvard Medical School. Active in clinical trials for anticoagulant therapies.

Labs/Teams: Member of the Vascular Biology and Therapeutics Program, Smilow Cancer Hospital’s Hematology program, and Yale Cancer Center. Leads interdisciplinary projects in translational hematology.